H4607
An Act relative to increasing access to epinephrine
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To Governor
- Became Law
Bill overview
This bill aims to improve access to epinephrine auto-injectors, commonly known as EpiPens, for individuals at risk of severe allergic reactions. It seeks to lower the cost of these devices and expand their availability, particularly in schools and other public places. The bill also addresses the potential for trained personnel to administer epinephrine in emergency situations. It is closely related to other legislation focused on epinephrine access and emergency preparedness.
Key provisions
- Expedite the approval process for new epinephrine auto-injector products.
- Establish a program to provide financial assistance to individuals who cannot afford epinephrine.
- Require schools and other institutions to maintain an adequate supply of epinephrine.
- Allow trained school personnel to administer epinephrine without a prescription.
- Promote the distribution of epinephrine in underserved communities.
Who is affected
- Individuals with allergies
- Schools and educational institutions
- Healthcare providers
- Pharmacies
- Emergency medical services
Notable changes
- The bill references and incorporates elements of previously introduced legislation (H.2367, H.2500, H.2503, H.590, H.611, and H.1962).
- It expands the role of trained personnel in administering epinephrine.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Joint Committee on Public Health
Cosponsors
Adrian C. Madaro
Bruce J. Ayers
Carmine Lawrence Gentile
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.
Bill H.4607 194th (Current)
An Act relative to increasing access to epinephrine
View Text Print Preview Download PDF
Bill Information
Bill Information
Sponsor: Joint Committee on Public Health Status: Referred to House Committee on Ways and Means
Tabs
Bill History Cosponsors Committee Vote Fiscal Note Committee Summary
Bill History
Displaying 4 actions for Bill H.4607
| Date | Branch | Action |
| 10/16/2025 | House | Reported from the committee on Public Health |
| 10/16/2025 | House | New draft of H2367, H2500 and H2503 |
| 10/16/2025 | House | Reported favorably by committee and referred to the committee on Health Care Financing |
| 12/4/2025 | House | Committee recommended bill ought to pass and referred to the committee on House Ways and Means |
Similar Bills
H.2500 194th (Current)
An Act relative to increasing access to epinephrine
H.590 194th (Current)
An Act relative to emergency stock supply of epinephrine in schools
H.1962 194th (Current)
An Act relative to police use of epinephrine autoinjectors
H.611 194th (Current)
An Act relative to emergency stock epinephrine in schools
H.2367 194th (Current)
An Act enabling trained school personnel to administer life saving epinephrine treatment
The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.